Cargando…
Engineered T lymphocytes eliminate lung metastases in models of pancreatic cancer
Pancreatic cancer is known as one of the most lethal cancers in the world. A majority of advanced stage pancreatic cancer patients are diagnosed with distant metastasis and given poor prognoses, calling for a better therapeutic option. Mesothelin, which is overexpressed in pancreatic cancer and othe...
Autores principales: | Sun, Qiang, Zhou, Shixin, Zhao, Jingjing, Deng, Changwen, Teng, Ruidi, Zhao, Yiding, Chen, Jiajia, Dong, Jiebin, Yin, Ming, Bai, Yun, Deng, Hongkui, Wen, Jinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862608/ https://www.ncbi.nlm.nih.gov/pubmed/29568387 http://dx.doi.org/10.18632/oncotarget.24122 |
Ejemplares similares
-
Chimeric Antigen Receptor–modified T Cells Repressed Solid Tumors and Their Relapse in an Established Patient-derived Colon Carcinoma Xenograft Model
por: Teng, Ruidi, et al.
Publicado: (2019) -
Enhancing T cell anti-tumor efficacy with a PD1-TIGIT chimeric immune-checkpoint switch receptor
por: Zhao, Jingjing, et al.
Publicado: (2023) -
Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA
por: Bai, Yun, et al.
Publicado: (2015) -
Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA
por: Bai, Yun, et al.
Publicado: (2016) -
Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy
por: Zhang, Erhao, et al.
Publicado: (2018)